315031
Age of Sexual Debut and Physical Dating Violence Victimization: Gender differences among US High School Students
Methods: Data come from the 2009, 2011 and 2013 National Youth Risk Behavior Survey. Study population included 8,705 males and 8,207 females in grades 9 through 12. The association was examined using multivariate logistic regression models, stratified by gender. PDV was defined as physical violence by a date during the past 12 months and age of sexual debut, as age of first sexual intercourse.
Results: Sixteen percent of females and fourteen percent of males reported PDV victimization in the previous year. Among participants who experienced PDV, 22% reported initiating sex at ages 14 and 15 years respectively. In both males and females, the odds of PDV victimization increased with early sexual debut age. Males with sexual debut at ≤12 years had 40% higher odds of PDV victimization (OR: 2.3; 95% CI: 1.4-3.7) than females (OR: 1.9; 95% CI: 1.1-3.3) with same sexual debut age.
Conclusion: This study provides evidence that an early age of sexual debut is associated with higher odds of PDV victimization with males being disproportionately affected. It is therefore essential that parents, educators and counselors give particular attention to delaying sexual debut age in adolescents, especially males.
Learning Areas:
Administer health education strategies, interventions and programsEpidemiology
Learning Objectives:
Evaluate the gender-specific differences in the relationship between age of sexual debut and physical dating violence among high school students in the US.
Discuss the implication of these gender differences.
Keyword(s): Domestic Violence, Youth Violence
Qualified on the content I am responsible for because: I am part of a research team investigating physical dating violence and intimate partner violence. Among my scientific interests has been the the relationship between age of sexual debut and physical dating violence victimization.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.